BEGIN:VCALENDAR VERSION:2.0 PRODID:-//PsychU - ECPv6.1.4//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:PsychU X-ORIGINAL-URL:https://psychu.org X-WR-CALDESC:Events for PsychU REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/Los_Angeles BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20240310T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20241103T090000 END:STANDARD TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20240310T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20241103T060000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20240501T120000 DTEND;TZID=America/Los_Angeles:20240501T130000 DTSTAMP:20240413T204437 CREATED:20240325T193642Z LAST-MODIFIED:20240402T211610Z UID:10004053-1714564800-1714568400@psychu.org SUMMARY:Virtual Event – Is It MDD Or Bipolar Disorder? DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Testing Event – WP SMTP Delay\n This is a National Virtual Event for all PsychU members. \nIn this presentation\, the objectives are to: \n\nReview the prevalence and burden of major depressive disorder (MDD) and bipolar disorder (BD)\nDiscuss the clinical features of MDD and BD\nAddress the difficulties in differential diagnosis between MDD and BD \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Chet Robachinski\, MD\n Psychiatric Director\, Bailey-Boushay House\, Seattle\, WA; Founding Partner\, Associates in Behavioral Health \n \n \n \n\n\n \n \n \n \n Simon Kim\, PharmD (OPDC)\n Medical & Scientific Liaison \n \n \n \n\n\nSpeaker Chet Robachinski\, MD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC)Speaker Simon Kim\, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Exploring Post-Traumatic Stress Disorder: Treatment Landscape & Unmet Needs Part 2\n \n On-Demand Webinar April 10\, 2024\n \n This part 2\, on-demand webinar\, examines the current PTSD treatment landscape\, including discussions on both psychotherapy and pharmacotherapy. In addition\, presenters review limitations and key considerations in the treatment of… \n \n \n PsychU Sizzle Reel\n \n Video April 4\, 2024\n \n Join us for this opportunity to learn and grow as we all strive to improve our mental health… together! \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. URL:https://psychu.org/event/virtual-event-collaborative-care-in-mental-health/ LOCATION:CA CATEGORIES:National,Virtual & Live Events ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/04/Virtual-Event_912x506_shutterstock_2069741450.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240501T120000 DTEND;TZID=America/New_York:20240501T130000 DTSTAMP:20240413T204437 CREATED:20240403T230816Z LAST-MODIFIED:20240405T124838Z UID:10004063-1714564800-1714568400@psychu.org SUMMARY:Virtual Event - Social Determinants Of Health DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Testing Event – WP SMTP Delay\n This is a Virtual Event for PsychU members in Delaware\, Maryland\, New Jersey\, Pennsylvania\, and West Virginia. \nIn this presentation\, the objectives are to: \n\nDiscuss health equity and social determinants of health (SDoH)\nWhat is the relationship to population health?\nDiscuss how SDoH impacts the economics of the population\nDiscuss a recent pandemic’s impact and correlation to SDoH\nDiscuss how payors utilize SDoH data to influence decisions and program investments\nDiscuss how SDoH can impact value-based payment methods \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Michael Townsend\, MA\, LSW/LCSW\n Deputy Chief Executive Officer\, Gateway Counseling Center \n \n \n More\n \n Mr. Townsend\, is the Deputy Chief Executive Officer at Gateway Counseling Center where he assists the Chief Executive Officer (CEO) with managing and directing the organization towards its primary objectives\, serves as a member of the Boardof Directors\, as well as the Chair of Audit Committee of the Mental Health Association in New York\, and is also the President of GCC Transportation\, LLC\, which directs transportation services to the transit disabled and medically frail.\n \n \n\n\n \n \n \n \n Becky Wong\, PharmD\, MBA (OPDC)\n Medical Science Director \n \n \n \n\n\nSpeaker Michael Townsend\, MA\, LSW/LCSW is a paid consultant for Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC)Becky Wong\, PharmD\, MBA is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Exploring Post-Traumatic Stress Disorder: Treatment Landscape & Unmet Needs Part 2\n \n On-Demand Webinar April 10\, 2024\n \n This part 2\, on-demand webinar\, examines the current PTSD treatment landscape\, including discussions on both psychotherapy and pharmacotherapy. In addition\, presenters review limitations and key considerations in the treatment of… \n \n \n PsychU Sizzle Reel\n \n Video April 4\, 2024\n \n Join us for this opportunity to learn and grow as we all strive to improve our mental health… together! \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. URL:https://psychu.org/event/virtual-event-social-determinants-of-health/ LOCATION:CA CATEGORIES:Regional/Local,Virtual & Live Events ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/04/Virtual-Event_912x506_shutterstock_2069741450.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240508T120000 DTEND;TZID=America/New_York:20240508T130000 DTSTAMP:20240413T204437 CREATED:20240402T224144Z LAST-MODIFIED:20240405T123211Z UID:10004059-1715169600-1715173200@psychu.org SUMMARY:Virtual Event - Agitation Associated With Alzheimer’s Dementia Disease State Education: Clinical\, Humanistic & Economic Burden DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Testing Event – WP SMTP Delay\n This is a Virtual Event for PsychU Members in Delaware\, Maryland\, New Jersey\, Pennsylvania\, and West Virginia. \n In this presentation\, topics of discussion are: \n\nClinical burden\nHumanistic burden\nEconomic burden\nAAD is associated with substantial patient burden and long-term consequences\n \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n E. Jeffrey Greenberg\, MD\n Neurologist at Princeton & Rutgers Neurology\, P.A.\, Co-Founder of Advanced Clinical Institute \n \n \n More\n \n Dr. Jeffrey Greenberg\, a native of Philadelphia\, joined Princeton & Rutgers Neurology in 2003. He received his Bachelor’s degree in English from Cornell University and his medical degree from Drexel University\, College of Medicine. He completed his Neurology residency at the Albert Einstein College of Medicine in New York\, serving as Chief Resident in his final year. He subsequently completed an EMG/Neuromuscular fellowship at Albert Einstein. He is Board Certified in Neurology by the American Board of Psychiatry and Neurology and also Board Certified by the American Associate of Neuromuscular and Electrodiagnostic Medicine.\n\nDr. Greenberg now focuses his practice on Parkinson’s Disease\, Dementia\, Multiple Sclerosis\, and Neuromuscular Disease. Additionally\, he has experience as a Principle Investigator for Alzheimer’s disease clinical trials and remains involved in the field.\n \n \n\n\n \n \n \n \n Becky Wong\, PharmD\, MBA (OPDC)\n Medical Science Director \n \n \n \n\n\nSpeaker E. Jeffrey Greenberg\, MD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC)Speaker Becky Wong\, PharmD\, MBA is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Exploring Post-Traumatic Stress Disorder: Treatment Landscape & Unmet Needs Part 2\n \n On-Demand Webinar April 10\, 2024\n \n This part 2\, on-demand webinar\, examines the current PTSD treatment landscape\, including discussions on both psychotherapy and pharmacotherapy. In addition\, presenters review limitations and key considerations in the treatment of… \n \n \n PsychU Sizzle Reel\n \n Video April 4\, 2024\n \n Join us for this opportunity to learn and grow as we all strive to improve our mental health… together! \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. URL:https://psychu.org/event/virtual-event-agitation-associated-with-alzheimers-dementia-disease-state-education-clinical-humanistic-economic-burden/ LOCATION:CA CATEGORIES:Regional/Local,Virtual & Live Events ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/04/Virtual-Event_912x506_shutterstock_2069741450.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240516T120000 DTEND;TZID=America/New_York:20240516T130000 DTSTAMP:20240413T204437 CREATED:20240405T203534Z LAST-MODIFIED:20240411T213653Z UID:10004064-1715860800-1715864400@psychu.org SUMMARY:Exploring Post-Traumatic Stress Disorder: Pathophysiology DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Testing Event – WP SMTP Delay\n Although there may be many etiologies\, Post-Traumatic Stress Disorder (PTSD) is a dynamic disorder that involves fluctuations between contrasting forms of emotional dysregulation.1 This webinar will provide a high-level overview of the pathophysiology of PTSD\, including discussion of the potential role of monoamine neurotransmitter systems involved in emotional regulation and fear response in the amygdala.\n\n\nReferences:\n1. Yehuda R\, et al. Nat Rev Dis Primers. 2015;1:15057. \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Steven Stoner\, PharmD\n Associate Dean for Student Affairs/Clinical Professor\, University of Missouri-Kansas City School of Pharmacy \n \n \n More\n \n Steven Stoner\, PharmD\, BCPP\, is Board Certified in Psychiatric Pharmacy. He is the associate dean of Student Affairs and a Clinical Professor at the UMKC School of Pharmacy. He received his PharmD from the University of Nebraska College of Pharmacy. Dr. Stoner completed a postdoctoral residency in psychiatric pharmacy practice and administration and a fellowship at Western Missouri Mental Health Center in Kansas City\, Missouri.\n \n \n\n\n \n \n \n \n Miranda Fisher\, PhD (OPDC)\n Medical Science Liaison \n \n \n \n\n\nSpeaker Steven Stoner\, PharmD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC)Speaker Miranda Fisher\, Phd. is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Exploring Post-Traumatic Stress Disorder: Treatment Landscape & Unmet Needs Part 2\n \n On-Demand Webinar April 10\, 2024\n \n This part 2\, on-demand webinar\, examines the current PTSD treatment landscape\, including discussions on both psychotherapy and pharmacotherapy. In addition\, presenters review limitations and key considerations in the treatment of… \n \n \n PsychU Sizzle Reel\n \n Video April 4\, 2024\n \n Join us for this opportunity to learn and grow as we all strive to improve our mental health… together! \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. URL:https://psychu.org/event/exploring-post-traumatic-stress-disorder-pathophysiology/ LOCATION:CA CATEGORIES:Webinar ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2024/04/Shutterstock_2073271901.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240516T183000 DTEND;TZID=America/New_York:20240516T203000 DTSTAMP:20240413T204437 CREATED:20240325T133553Z LAST-MODIFIED:20240405T135439Z UID:10004052-1715884200-1715891400@psychu.org SUMMARY:Importance Of Adherence On Individuals With Bipolar Disorder DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Testing Event – WP SMTP Delay\n This is a Live Event for PsychU members in Connecticut. \nTreatment non-adherence is a dilemma in bipolar disorder and is one of the leading challenges in providing effective treatments for people diagnosed with BP I disorder. During our discussion today\, the speaker will discuss and define some of these challenges and provide the latest information on treatment-related determinants of adherence. We will also discuss some of the factors important to adherence. \n \n\n\n\n\n\n\n \n Venue\n \n \n\n\n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Joseph Goldberg\, MD\n Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai\n \n \n \n More\n \n Dr. Goldberg currently serves as the Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai and serves on the Board of Directors for the American Society of Clinical Psychopharmacology. Dr. Goldberg has published over 200 peer-reviewed papers on topics related to the treatment and clinical features of bipolar disorder\, as well as three books on bipolar disorder and psychopharmacology.\n \n \n\n\n \n \n \n \n Jehan Marino\, PharmD\, BCPP (OPDC)\n Medical Science Liaison \n \n \n \n\n\n \n \n \n \n Yasmin Togun\, PhD (OPDC)\n Medical Science Liaison \n \n \n More\n \n Dr. Yasmin Togun is a CNS Medical Science Liaison at Otsuka\, covering Connecticut\, Massachusetts. Rhode Island\, Vermont\, New Hampshire\, and Maine. She is a Licensed Clinical Psychologist with a focus on Pediatric Psychology and Health Service Psychology. Prior to joining Otsuka\, she practiced as an Attending Psychologist on the Psychiatry Consultation Liaison Service at Boston Children’s Hospital and a Clinical Instructor of Psychology at Harvard Medical School.\n \n \n\n\nSpeaker Joseph Goldberg\, MD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC)Speakers Jehan Marino\, PharmD\, BCPP and Yasmin Togun\, PhD are employees of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\nPSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS \n PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc.\, Otsuka America Pharmaceutical\, Inc.\, and Lundbeck\, L.L.C.\, committed supporters of the mental health treatment community; as such\, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs. \n PSYCHU MEMBERSHIP ELIGIBILITY \n In accordance with the PhRMA Code on Interactions with Healthcare Professionals\, attendance at PsychU educational programs is limited to appropriate attendees (e.g.\, physician\, clinical professional\, current medical school student\, care manager\, advocate\, recovery coach or an executive and manager of an organization) whose primary role is to provide\, manage\, finance\, study\, or regulate mental health services for adult patients.\n NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements. \n MEMBERSHIP & REGISTRATION \n Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU\, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program\, please visit https://www.PsychU.org/. \n ATTENDANCE LIMITATIONS \n PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs\, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs\, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions\, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com. \n MEAL REPORTING \n The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws. URL:https://psychu.org/event/importance-of-adherence-on-individuals-with-bipolar-disorder/ LOCATION:Craft Kitchen + Bar\, 93 Mill Plain Rd\, Danbury\, CT\, 06811\, United States CATEGORIES:Live Event ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/04/Live-Event_912x506_shutterstock_1352113667.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240522T120000 DTEND;TZID=America/New_York:20240522T130000 DTSTAMP:20240413T204437 CREATED:20240313T155129Z LAST-MODIFIED:20240405T200044Z UID:10004048-1716379200-1716382800@psychu.org SUMMARY:Virtual Event - Care Coordination For Adult Patients With SMI - From Inpatient To Outpatient DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Testing Event – WP SMTP Delay\n This is a Virtual Live Event for PsychU members in Delaware\, Maryland\, New Jersey\, New York\, Pennsylvania\, and West Virginia. \nIn this presentation\, topics of discussion are: \n\nProgram introduction\nClinical course of serious mental illness (SMI)\nRisk factors for relapse/recurrence\nDiscussion of coordination of care and discharge planning\nHypothetical profile of a patient with SMI \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Salvatore G. Savatta\, MD\n Chair of Psychiatry\, Trinitas Regional Medical Center\, Elizabeth\, NJ \n \n \n More\n \n Dr. Salvatore G. Savatta received his Bachelor of Arts degree in Economics from New York University\, graduated from New York University School of Medicine in 2001 and completed his M.S. in Biostatistics Clinical Research Methods at Columbia University’s Mailman School of Public Health in 2005. Dr. Savatta has previously served as Director of Inpatient Psychiatry at New York Methodist Hospital\, Medical Director of TMS Centers of America and both Deputy Chair and Interim Chair of Psychiatry at Trinitas Regional Medical Center. He presently serves as Chair of Psychiatry at Trinitas and has done so since May of 2020.\nDr. Savatta completed his Psychiatry Residency at St. Vincent’s Catholic Medical Center and completed a Public Service Psychiatry Fellowship and a Forensic Psychiatry Fellowship at the University of Pittsburgh Medical Center – Western Psychiatric Institute and Clinic. Dr. Savatta is Board Certified in both Adult Psychiatry and Forensic Psychiatry.\nHe has tailored his clinical practice to focus on “difficult to treat” depression\, and often includes the implementation of Neuromodulation techniques such as TMS\, Esketamine\, and Electroconvulsive Therapy (ECT) when clinically appropriate.\n \n \n\n\n \n \n \n \n Jehan Marino\, PharmD\, BCPP (OPDC)\n Medical Science Liaison \n \n \n \n\n\n \n \n \n \n Becky Wong\, PharmD\, MBA (OPDC)\n Medical Science Director \n \n \n \n\n\nSpeaker Salvatore G. Savatta\, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC)Speakers Jehan Marino\, PharmD\, BCPP and Becky Wong\, PharmD\, MBA are employees of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Exploring Post-Traumatic Stress Disorder: Treatment Landscape & Unmet Needs Part 2\n \n On-Demand Webinar April 10\, 2024\n \n This part 2\, on-demand webinar\, examines the current PTSD treatment landscape\, including discussions on both psychotherapy and pharmacotherapy. In addition\, presenters review limitations and key considerations in the treatment of… \n \n \n PsychU Sizzle Reel\n \n Video April 4\, 2024\n \n Join us for this opportunity to learn and grow as we all strive to improve our mental health… together! \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. URL:https://psychu.org/event/virtual-event-care-coordination-for-adult-patients-with-smi-from-inpatient-to-outpatient/ LOCATION:CA CATEGORIES:Regional/Local,Virtual & Live Events ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/04/Virtual-Event_912x506_shutterstock_2069741450.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240522T120000 DTEND;TZID=America/New_York:20240522T130000 DTSTAMP:20240413T204437 CREATED:20240411T140257Z LAST-MODIFIED:20240411T214305Z UID:10004066-1716379200-1716382800@psychu.org SUMMARY:Combating Self-Stigma In Persons With Serious Mental Illness (SMI) With Narrative Enhancement & Cognitive Therapy (NECT) DESCRIPTION:Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Testing Event – WP SMTP Delay\n Self-stigma refers to the negative attitudes\, including internalized shame\, that people with mental illness have about their condition.1 Many interventions are available to address self-stigma in the serious mental illness (SMI) population\, and one of them is Narrative Enhancement and Cognitive Therapy (NECT). NECT is a manualized group-based psychosocial intervention that is directed towards helping people who have been labeled with a psychiatric diagnosis recover their sense of value and decrease internalized/self-stigma.2\nCome and join us for this webinar\, moderated by Sara Spencer\, PharmD\, MS\, BCGP and featuring NECT founder\, Philip Yanos\, Ph.D.\, who will share the impact of internalized stigma on SMI individuals as well as the NECT methodology and provide a practical case vignette for implementation and application of this innovative therapy intervention into clinical practice.\nReference: \n\n\n Stigma\, Prejudice\, and Discrimination Against People with Mental Illness. American Psychiatric Association. Psychiatry.org – Stigma\, Prejudice\, and Discrimination Against People with Mental Illness. Accessed: March 2024.\n Narrative Enhancement and Cognitive Therapy. NECT Global. NECT Global\n \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Philip Yanos\, PhD\n Professor\, Department of Psychology\, John Jay College of Criminal Justice\, City University of New York \n \n \n \n\n\n \n \n \n \n Sara A. Spencer\, PharmD\, MS\, BCGP (OPDC)\n Medical Science Liaison \n \n \n \n\n\nSpeaker Sara Spencer\, PharmD\, MS\, BCGP is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Exploring Post-Traumatic Stress Disorder: Treatment Landscape & Unmet Needs Part 2\n \n On-Demand Webinar April 10\, 2024\n \n This part 2\, on-demand webinar\, examines the current PTSD treatment landscape\, including discussions on both psychotherapy and pharmacotherapy. In addition\, presenters review limitations and key considerations in the treatment of… \n \n \n PsychU Sizzle Reel\n \n Video April 4\, 2024\n \n Join us for this opportunity to learn and grow as we all strive to improve our mental health… together! \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n \n \n \n \n\n\n\n\n \n \n \n Home\n \n \n \n \n Events URL:https://psychu.org/event/combating-self-stigma-in-persons-with-serious-mental-illness-smi-with-narrative-enhancement-cognitive-therapy-nect/ LOCATION:CA CATEGORIES:Webinar ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2024/04/Shutterstock_1958619805.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240606T120000 DTEND;TZID=America/New_York:20240606T130000 DTSTAMP:20240413T204437 CREATED:20240402T224750Z LAST-MODIFIED:20240404T213529Z UID:10004060-1717675200-1717678800@psychu.org SUMMARY:Virtual Event - Unmet Needs In Agitation Associated With Alzheimer's Dementia (AAD) DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Testing Event – WP SMTP Delay\n This is a Virtual Event for PsychU members in Delaware\, Maryland\, New Jersey\, Pennsylvania\, and West Virginia. \nThis evidence-based review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) for better understanding of prevalence and challenges in diagnosis and explore the potential pathobiological correlations in AAD. Describes the clinical and humanistic burden and discusses current guidelines for nonpharmacological and pharmacological treatments of this complex and prominent complication of an already devastating disease. It underlines unmet needs for FDA-approved pharmaceutical treatments for agitation to improve care and quality of life for patients suffering from AAD. \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n E. Jeffrey Greenberg\, MD\n Neurologist at Princeton & Rutgers Neurology\, P.A.\, Co-Founder of Advanced Clinical Institute \n \n \n More\n \n Dr. Jeffrey Greenberg\, a native of Philadelphia\, joined Princeton & Rutgers Neurology in 2003. He received his Bachelor’s degree in English from Cornell University and his medical degree from Drexel University\, College of Medicine. He completed his Neurology residency at the Albert Einstein College of Medicine in New York\, serving as Chief Resident in his final year. He subsequently completed an EMG/Neuromuscular fellowship at Albert Einstein. He is Board Certified in Neurology by the American Board of Psychiatry and Neurology and also Board Certified by the American Associate of Neuromuscular and Electrodiagnostic Medicine.\n\nDr. Greenberg now focuses his practice on Parkinson’s Disease\, Dementia\, Multiple Sclerosis\, and Neuromuscular Disease. Additionally\, he has experience as a Principle Investigator for Alzheimer’s disease clinical trials and remains involved in the field.\n \n \n\n\n \n \n \n \n Becky Wong\, PharmD\, MBA (OPDC)\n Medical Science Director \n \n \n \n\n\nSpeaker E. Jeffrey Greenberg\, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC)Speaker Becky Wong\, PharmD\, MBA is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Exploring Post-Traumatic Stress Disorder: Treatment Landscape & Unmet Needs Part 2\n \n On-Demand Webinar April 10\, 2024\n \n This part 2\, on-demand webinar\, examines the current PTSD treatment landscape\, including discussions on both psychotherapy and pharmacotherapy. In addition\, presenters review limitations and key considerations in the treatment of… \n \n \n PsychU Sizzle Reel\n \n Video April 4\, 2024\n \n Join us for this opportunity to learn and grow as we all strive to improve our mental health… together! \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. URL:https://psychu.org/event/virtual-event-unmet-needs-in-agitation-associated-with-alzheimers-dementia-aad-5/ LOCATION:CA CATEGORIES:Regional/Local,Virtual & Live Events ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/04/Virtual-Event_912x506_shutterstock_2069741450.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241010T120000 DTEND;TZID=America/New_York:20241010T130000 DTSTAMP:20240413T204437 CREATED:20240319T141503Z LAST-MODIFIED:20240411T060949Z UID:10004050-1728561600-1728565200@psychu.org SUMMARY:The Danger of Post-Traumatic Stress Disorder (PTSD) Stigma Among Marginalized Communities DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Testing Event – WP SMTP Delay\n Marginalized communities are those excluded from mainstream social\, economic\, educational\, and/or cultural life. Examples include race\, age\, sexual orientation\, gender identity\, physical ability\, language and/or immigration status1. This webinar aims to raise awareness between post-traumatic stress disorder (PTSD) and the stigma associated with marginalized communities. A review of risk factors\, challenges in identification\, diagnosis\, and treatment of PTSD in this community will be explored; followed by a discussion of barriers to accessing care and how healthcare professionals can improve these challenges in practice. Join us for an informative webinar moderated by Haneefa Rakeeb DNP\, PMHNP-BC\, RN alongside esteemed speakers Christiian Storm Credle\, PsyD and Christopher Thomas Tobias\, MS\, MHA\, CHF\, PA-C. \n\nReferences:\n1. Sevelius\, J. M.\, et al. (2020). Research with Marginalized Communities: Challenges to Continuity During the COVID-19 Pandemic. AIDS and behavior\, 24(7)\, 2009–2012. https://doi.org/10.1007/s10461-020-02920-3 \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Christiian Storm Credle\, PsyD (he/him/his)\n Lead Mosaic Psychologist/Supervising Psychologist; Mosaic Medical Center for Lesbian\, Gay\, Bisexual\, Transgender\, and Queer+ Health and Wellness; Sharon Hill Medical\, AIDS Care Group\, Center for Integrative Medicine\, Sharon Hill\, PA\n \n \n \n \n\n\n \n \n \n \n Christopher Thomas Tobias\, MS\, MHA\, CHF\, PA-C (he/him/his)\n Director of Academic Education & Clinical Assistant Professor for Physician Studies at the School of Health Professions; Saint Joseph’s University\, Philadelphia\, PA\n \n \n \n \n\n\n \n \n \n \n Haneefa Rakeeb\, DNP\, PMHNP-BC\, AFN-BC (OPDC)\n Medical Science Liaison \n \n \n \n\n\nSpeakers Christtian Storm Credle\, PsyD and Christopher Thomas Tobias\, MS\, MHA\, CHF\, PA-C\, are paid consultants of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC)Speaker Haneefa Rakeeb\, DNP\, PMHNP-BC\, is a paid employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Exploring Post-Traumatic Stress Disorder: Treatment Landscape & Unmet Needs Part 2\n \n On-Demand Webinar April 10\, 2024\n \n This part 2\, on-demand webinar\, examines the current PTSD treatment landscape\, including discussions on both psychotherapy and pharmacotherapy. In addition\, presenters review limitations and key considerations in the treatment of… \n \n \n PsychU Sizzle Reel\n \n Video April 4\, 2024\n \n Join us for this opportunity to learn and grow as we all strive to improve our mental health… together! \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. URL:https://psychu.org/event/the-danger-of-post-traumatic-stress-disorder-ptsd-stigma-among-marginalized-communities/ LOCATION:CA CATEGORIES:Webinar ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2024/03/Shutterstock_299372693.jpg END:VEVENT END:VCALENDAR